Ivor MacLeod
Director of Finance/CFO chez SCYNEXIS, INC.
Fortune : 235 506 $ au 31/03/2024
Profil
Ivor MacLeod is currently the Chief Financial & Accounting Officer at SCYNEXIS, Inc. He previously held executive finance positions at Merck & Co., Inc., Hoffmann-La Roche, Inc., and Eisai, Inc. He was also the former Chief Financial & Accounting Officer at Athersys, Inc. from 2021 to 2022.
Mr. MacLeod received his undergraduate degree from the University of St. Andrews and his MBA from Eller College of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCYNEXIS, INC.
0,43% | 26/01/2024 | 160 185 ( 0,43% ) | 235 472 $ | 31/03/2024 |
ATHERSYS, INC.
0,01% | 14/08/2023 | 5 732 ( 0,01% ) | 34 $ | 31/03/2024 |
Postes actifs de Ivor MacLeod
| Sociétés | Poste | Début |
|---|---|---|
| SCYNEXIS, INC. | Director of Finance/CFO | 24/10/2022 |
Anciens postes connus de Ivor MacLeod
| Sociétés | Poste | Fin |
|---|---|---|
| ATHERSYS, INC. | Director of Finance/CFO | 30/06/2022 |
| MERCK & CO., INC. | Director of Finance/CFO | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Director of Finance/CFO | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director of Finance/CFO | - |
Formation de Ivor MacLeod
| University of St. Andrews | Undergraduate Degree |
| Eller College of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| ATHERSYS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
